Abstract
In this chapter, the reader will get acquainted with the clinical features, diagnosis, and treatment of multiple endocrine neoplasia type 1 (MEN1). The parathyroid, neuroendocrine, and pituitary tumors that are part of the syndrome are also discussed in detail in different chapters.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
de Laat JM, van der Luijt RB, Pieterman CRC, et al. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients. BMC Med. 2016;14(1):182. https://doi.org/10.1186/s12916-016-0708-1, indexed in Pubmed: 27842554.
KMa D, CJm L. Diagnosis and Management of Multiple Endocrine Neoplasia Type 1 (MEN1). Hered Cancer Clin Pract. 2005;3(1):1–6. https://doi.org/10.1186/1897-4287-3-1-1.
Ito T, Igarashi H, Uehara H, et al. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore). 2013;92(3):135–81. https://doi.org/10.1097/MD.0b013e3182954af1.
Marini F, Falchetti A, Del Monte F, et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Dis. 2006;1:38. https://doi.org/10.1186/1750-1172-1-38.
Thakker RV, Newey PJ, Walls GV, et al. Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97(9):2990–3011. https://doi.org/10.1210/jc.2012-1230.
van Beek D-J, et al. ‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1. Endocr Connect. 2018;7(11):R260–74. Endocr Connect. 2018; 7(11):R260–R274. https://doi.org/10.1530/EC-18-0359.
van Leeuwaarde RS, de Laat JM, Pieterman CRC, et al. The future: medical advances in MEN1 therapeutic approaches and management strategies. Endocr Relat Cancer. 2017;24(10):T179–93. https://doi.org/10.1530/ERC-17-0225.
Yates CJ, Newey PJ, Thakker RV. Challenges and controversies in management of pancreatic neuroendocrine tumors in patients with MEN1. Lancet Diabetes Endocrinol. 2015;3(11):895–905. https://doi.org/10.1016/S2213-8587(15)00043-1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gilis-Januszewska, A., Trofimiuk-Müldner, M., Skalniak, A., Hubalewska-Dydejczyk, A. (2021). Multiple Endocrine Neoplasia Type 1. In: Igaz, P. (eds) Practical Clinical Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-62011-0_50
Download citation
DOI: https://doi.org/10.1007/978-3-030-62011-0_50
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-62010-3
Online ISBN: 978-3-030-62011-0
eBook Packages: MedicineMedicine (R0)